Search Results - timothy+acker

1 Results Sort By:
GluN2C/D-selective Antagonists for Treatment of Neurological Disorders
Application A new series of compounds for selectively inhibiting N-methyl-D-aspartate (NMDA) receptor subunits for the treatment of Parkinson's disease, schizophrenia, treatment-resistant depression, and ischemia. Key Benefits Improved anatomical selectivity in NMDA receptor modulation may result in fewer adverse side effects. Targeted antagonism...
Published: 8/22/2024   |   Inventor(s): Timothy Acker, Stephen Traynelis, Dennis Liotta
Keywords(s): Neuroscience/Pain, Small Molecule
Category(s): TechPub Algolia > Therapeutics